[go: up one dir, main page]

HK40000761B - Biologically active cannabidiol analogs - Google Patents

Biologically active cannabidiol analogs Download PDF

Info

Publication number
HK40000761B
HK40000761B HK19124074.6A HK19124074A HK40000761B HK 40000761 B HK40000761 B HK 40000761B HK 19124074 A HK19124074 A HK 19124074A HK 40000761 B HK40000761 B HK 40000761B
Authority
HK
Hong Kong
Prior art keywords
cbd
mono
val
morphine
vhs
Prior art date
Application number
HK19124074.6A
Other languages
German (de)
English (en)
Chinese (zh)
Other versions
HK40000761A (en
Inventor
Mahmoud A. Elsohly
Soumyajit Majumdar
Waseem Gul
Mohammad Khalid Ashfaq
Kenneth Joseph SUFKA
Hannah Marie HARRIS
Original Assignee
The University Of Mississippi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Of Mississippi filed Critical The University Of Mississippi
Publication of HK40000761A publication Critical patent/HK40000761A/en
Publication of HK40000761B publication Critical patent/HK40000761B/en

Links

Claims (6)

  1. Analogue biologiquement actif du cannabidiol (CBD), l'analogue actif du cannabidiol étant la CBD-Di-AlaninateDi-Hémisuccinate, le CBD-Di-Valinate-Di-Hémisuccinate, le CBD-Mono -Valinate-Mono-Hémisuccinate ou le CBD-Monovalinate-Di-Hémisuccinate, le CBD-Mono-Valinate- Mono-Hémisuccinate ayant la formule :
  2. Analogue biologiquement actif du cannabidiol (CBD) selon la revendication 1, l'analogue biologiquement actif du cannabidiol (CBD) étant le CBD-divalinate-Di-hémisuccinate.
  3. Analogue biologiquement actif du cannabidiol (CBD) selon la revendication 1, l'analogue biologiquement actif du cannabidiol (CBD) étant le CBD-monovalinate-Di-Hémisuccinate.
  4. Analogue biologiquement actif du cannabidiol (CBD) selon la revendication 1, l'analogue biologiquement actif du cannabidiol (CBD) étant le CBD-Monovalinate-Mono-Hémisuccinate.
  5. Composition pharmaceutique comprenant un analogue biologiquement actif du cannabidiol selon la revendication 1 dans un support pharmaceutiquement acceptable.
  6. Composition pharmaceutique selon la revendication 5, l'analogue biologiquement actif du cannabidiol étant le CBD-Monovalinate-Mono-Hémisuccinate.
HK19124074.6A 2016-01-29 2017-01-27 Biologically active cannabidiol analogs HK40000761B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62/289,184 2016-01-29

Publications (2)

Publication Number Publication Date
HK40000761A HK40000761A (en) 2020-02-14
HK40000761B true HK40000761B (en) 2024-02-16

Family

ID=

Similar Documents

Publication Publication Date Title
US11337951B2 (en) Biologically active cannabidiol analogs
US9630941B2 (en) Compositions containing delta-9-THC-amino acid esters and process of preparation
EP3615079B1 (fr) Formulations de cannabinoïdes stables
EP2600851B1 (fr) Forme galénique et pharmaceutique comprenant 6'-fluoro-(n-méthyl- ou n,n-diméthyl-)-4-phényl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine pour le traitement de la douleur neuropathique
US20220054450A1 (en) Stable cannabinoid formulations
CN109562281A (zh) 酚类trpv1激动剂的前药与局部麻醉药和血管收缩剂联合用于改善局部麻醉
JP2015511934A (ja) スタチンの舌下投与
US20250114320A1 (en) Microspheres for extended release of fenofibrate
HK40000761A (en) Biologically active cannabidiol analogs
HK40000761B (en) Biologically active cannabidiol analogs
BR112018015570B1 (pt) Análogos de canabidiol biologicamente ativos, composição farmacêutica e uso dos mesmos
BR112019018700A2 (pt) composições farmacêuticas e seus usos
US20080255238A1 (en) Composition containing a thiourea derivative for preventing or treating pruritic or irritant skin diseases
JP2025527573A (ja) Ｃｄｋ９阻害剤の吸入可能な組成物